PUBLISHER: The Business Research Company | PRODUCT CODE: 1829828
PUBLISHER: The Business Research Company | PRODUCT CODE: 1829828
Vaccine delivery devices are mechanisms or systems devised to safely and efficiently administer vaccines to individuals. Engineered with precision, these tools guarantee precise dosage, accurate delivery, and minimal discomfort for the recipient. Their significance in public health endeavors lies in their ability to facilitate the distribution and application of vaccines, thereby thwarting the spread of infectious diseases.
The primary categories of vaccine delivery devices comprise needle-free injection systems, oral delivery systems, nasal delivery systems, jet injectors, microneedle patches, and microinjectors. Needle-free injection systems are medical tools designed to administer medication into the skin without employing a conventional needle. They facilitate various routes of administration, including intradermal, intramuscular, and subcutaneous vaccination, and are utilized by a range of end-users, including hospitals and clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The vaccine delivery devices market research report is one of a series of new reports from The Business Research Company that provides vaccine delivery devices market statistics, including the vaccine delivery devices industry global market size, regional shares, competitors with vaccine delivery devices market share, detailed vaccine delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the vaccine delivery devices industry. These vaccine delivery devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The vaccine delivery devices market size has grown strongly in recent years. It will grow from $6.39 billion in 2024 to $7.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to large-scale polio vaccination campaigns, expanded program on immunization (EPI), the adoption of disposable syringes, smallpox eradication efforts, initiatives including the global alliance for vaccines and immunization (GAVI) and the vaccine alliance.
The vaccine delivery devices market size is expected to see strong growth in the next few years. It will grow to $10.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pediatric and geriatric populations, focus on cold chain management, and raising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include the continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, new self-administered vaccines, and the partnerships.
The forecast of 9.5% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for microneedle array patches and auto-disable syringe mechanisms, sourced from key regions such as Japan and Switzerland, could lead to immunization delays and higher vaccination program costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rise in infectious diseases prevalence is poised to drive the expansion of the vaccine delivery devices market. Infectious diseases, caused by various microorganisms such as bacteria, viruses, fungi, or parasites, spread through various means including person-to-person contact, animals, vectors, or contaminated substances. Factors contributing to the prevalence of infectious diseases include increased global travel, rapid urbanization, shifts in climate patterns, and population expansion. Vaccine delivery devices play a pivotal role in disease prevention by effectively administering vaccines to populations, bolstering immunity, and curbing transmission rates. For instance, as reported by the World Health Organization (WHO) in November 2023, approximately 10.6 million cases of tuberculosis (TB) were reported worldwide in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. Consequently, the pervasive presence of infectious diseases underpins the growth of the vaccine delivery devices market.
Major companies in the vaccine delivery devices sector are innovating by introducing products such as prefillable syringes to improve the effectiveness and safety of vaccine delivery. Prefillable syringes are designed to securely contain and dispense a predetermined dosage of medication, typically in liquid form, specifically for vaccines. For example, in September 2022, Becton, Dickinson, and Company (BD), a US-based medical technology firm, launched the BD Effivax Glass Prefillable Syringe. This advanced vaccine delivery device aims to address the evolving requirements of vaccine production by enhancing reliability and efficiency in vaccine administration. The syringe incorporates enhanced technology and stricter specifications to provide increased fill or finish reliability and container durability, thereby reducing the risk of production interruptions and enhancing manufacturing capabilities.
In January 2022, ICU Medical Inc., a US-based producer of cutting-edge medical equipment utilized in infusion therapy, purchased Smiths Medical from Smiths Group plc for an undisclosed sum. This acquisition was aimed at integrating syringe and ambulatory infusion devices, vascular access tools, and essential care products into ICU Medical's range. Smiths Medical, a US-based company, specializes in vaccine delivery devices.
Major companies operating in the vaccine delivery devices market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis International AG, AstraZeneca PLC, 3M Company, GlaxoSmithKline plc, Moderna Inc., Becton Dickinson and Company (BD), Sinovac Biotech Co. Ltd., CSL Limited, INOVIO Pharmaceuticals Inc., Terumo Corporation, SCHOTT AG, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Dynavax Technologies Corporation, CanSino Biologics Inc., Vaxxas Inc., PharmaJet Inc., Enesi Pharma Limited, NanoPass Technologies Ltd., Gerresheimer AG, Panacea Biotec Limited
North America was the largest region in the vaccine delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the vaccine delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vaccine delivery devices market consists of sales of jet injectors, auto-injectors, oral vaccine delivery, microneedle patches, transdermal patches, inhalers, and intradermal devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vaccine Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on vaccine delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for vaccine delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vaccine delivery devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.